NYSEARCA:XLV

The Health Care Select Sector Spdr Fund ETF News

etoro logo Buy XLV
*Your capital is at risk
$152.18
+2.12 (+1.41%)
At Close: Jun 23, 2026

Finding Opportunity in Unloved Healthcare ETFs

11:02am, Friday, 31'st May 2024
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

FOMO Rally Gains Momentum? ETF Strategies to Play

02:00pm, Thursday, 30'th May 2024
Per the legendary investor John Hussman -- famous for predicting the 2000 and 2008 crashes, the latest stock rally is ingrained in the extreme fear of missing out. This FOMO rally may fizzle if the co
The Health Care Select Sector SPDR ETF (XLV) was launched on 12/16/1998, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equit
In April, inflationary pressures showed signs of easing. However, a few sectors and stocks that may gain in the near term as the price gains remained steady in those business areas.
The healthcare sector is one that exhibits "inelastic demand" and has the unique advantage of being essential to peoples' lives. Healthcare's valuation has been stunted by risks such as the "patent cl

Fighting Obesity Using ETFs

03:32pm, Monday, 13'th May 2024
Weight loss has long been a challenge for many people, me included. Indeed, there are an estimated 1 billion individuals living with obesity, and the Obesity World Atlas estimates this could rise to 1
Aaron Dunn, co-head of value equity at Morgan Stanley Investment Management, joins CNBC's 'The Exchange' to discuss opportunities in healthcare, why he thinks the sector is undervalued, and more.
The biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments while offering investors the possibility of significant returns. However, investing in these compani
The U.S. economy added 175, 000 jobs in April, well below Wall Street expectations of 240, 000.

ETF Asset Report of April

02:01pm, Friday, 03'rd May 2024
Performance-wise April became the worst month of 2024 for Wall Street. However, the S&P 500, the total stock market and the total bond market ETFs witnessed maximum asset accumulation in the month.
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
A trio of top 10 holdings from this S&P 500 healthcare sector ETF report this week (LLY, the largest holding, PFE and AMGN). Despite being loaded with quality businesses, this sector is not showing si
The Investment Committee share their pullback playbook for today's down market.
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline
UBS pointed out that rapid earnings growth recorded by the big six tech giants over the past year is now ebbing. Hence, this could be the time to bet on non-cyclical sectors.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE